ClinicalTrials.gov
ClinicalTrials.gov Menu

IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis (IMAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00144885
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : February 12, 2009
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris

Brief Summary:
Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.

Condition or disease Intervention/treatment Phase
Endocarditis, Bacterial Behavioral: Modification of therapy Not Applicable

Detailed Description:

Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.

Resonance magnetic imaging (head and abdomen) will be performed systematically before Day 7.

The impact on the diagnosis and therapeutic options will be assessed, as compared to pre resonance magnetic nuclear (RMN) imaging declaration.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact
Study Start Date : June 2005
Actual Primary Completion Date : December 2008
Actual Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endocarditis
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: 1 Behavioral: Modification of therapy
Modification of the surgery date if adapted, modification of the antibiotics if adapted, based on RMI results



Primary Outcome Measures :
  1. Modification of therapeutic project [ Time Frame: As soon as RMI is performed ]

Secondary Outcome Measures :
  1. Modification of diagnostic classification (Duke modified criteria) [ Time Frame: As soon as RMI is performed ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Acute phase of infective endocarditis

Exclusion Criteria:

  • Contra indication to RMN

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00144885


Locations
France
Hôpital Bichat Claude Bernard, 46 rue Henri Huchard
Paris, France, 75877
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Xavier Duval Hôpital Bichat, Assistance Publique Hôpitaux de Paris

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Zakia IDIR, Department Clinical Research of Developpement
ClinicalTrials.gov Identifier: NCT00144885     History of Changes
Other Study ID Numbers: P040431
First Posted: September 5, 2005    Key Record Dates
Last Update Posted: February 12, 2009
Last Verified: September 2005

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Endocarditis
RMI
Impact measure

Additional relevant MeSH terms:
Endocarditis
Endocarditis, Bacterial
Heart Diseases
Cardiovascular Diseases
Bacterial Infections
Cardiovascular Infections
Infection